Urology (PRP Therapy)

PRP therapy (platelet-rich plasma) is used in urology as a supportive treatment for chronic inflammatory diseases of the urinary tract. It is based on autologously obtained plasma with growth factors that can support regenerative processes in the tissue.

The aim of the treatment is the accompanying support of mucosal regeneration, the improvement of local healing processes, and the possible reduction of inflammation-associated complaints. The application is carried out within the framework of medical indication and as a supplement to established urological therapies.

Injection Areas and Procedure

PRP is used as a supplement for:

  • Chronic cystitis (including therapy-resistant cases)
  • Chronic urethritis
  • Chronic pelvic pain syndrome / chronic prostatitis
  • Inflammatory changes of the urinary tract mucosa
  • Mucosal lesions in the area of the bladder or urethra (depending on indication)

  • Support of urothelial and mucosal regeneration
  • Promotion of local blood circulation and tissue healing
  • Modulation of inflammatory processes in the tissue
  • Accompanying improvement of healing processes in chronic conditions
The scientific evidence is indication-dependent and, especially in chronic urological pain and inflammation syndromes, is still the subject of ongoing research. PRP is currently mainly used as an adjuvant therapy within multimodal treatment concepts.

The application is local, for example, intravesically (into the bladder) or periurethrally, depending on the clinical concept and indication. PRP is generally used as a supplement to conservative urological standard therapies.

Combination with other treatment methods is possible, especially:

  • Drug therapy (e.g., anti-inflammatory or antimicrobial)
  • Physiotherapeutic procedures (e.g., pelvic floor therapy, physical therapy forms)
  • Further supportive measures within a multimodal therapy concept